| 12281124 |
Heterocyclic compounds as monoacylglycerol lipase inhibitors |
Charles BELL, Joerg Benz, Luca Gobbi, Katrin Groebke Zbinden, Benoit Hornsperger +9 more |
2025-04-22 |
| 12180196 |
Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2 |
Simon M. Ametamey, Luca Gobbi, Julian Kretz |
2024-12-31 |
| 12071420 |
Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2 |
Luca Gobbi, Julian Kretz, Simon M. Ametamey |
2024-08-27 |
| 11999710 |
Radiolabeled cannabinoid receptor 2 ligand |
Simon M. Ametamey, Luca Gobbi, Julian Kretz, Dieter Muri, Ahmed Haider Wahauib |
2024-06-04 |
| 11981661 |
Heterocyclic compounds |
Joerg Benz, Benoit Hornsperger, Carsten KROLL, Bernd Kuhn, Rainer E. Martin +4 more |
2024-05-14 |
| 11814375 |
Heterocyclic compounds |
Joerg Benz, Luca Gobbi, Katrin Groebke Zbinden, Benoit Hornsperger, Carsten KROLL +6 more |
2023-11-14 |
| 11802133 |
Heterocyclic compounds as monoacylglycerol lipase inhibitors |
Charles BELL, Joerg Benz, Luca Gobbi, Katrin Groebke Zbinden, Benoit Hornsperger +9 more |
2023-10-31 |
| 11655243 |
Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists |
Simon M. Ametamey, Kenneth Atz, Luca Gobbi, Wolfgang Guba, Julian Kretz |
2023-05-23 |
| 11608347 |
Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors |
Ann Catherine Petersen, Joerg Benz, Benoit Hornsperger, Buelent Kocer, Bernd Kuhn +4 more |
2023-03-21 |
| 11420961 |
Heterocyclic compounds |
Joerg Benz, Benoit Hornsperger, Buelent Kocer, Bernd Kuhn, Hans Richter +5 more |
2022-08-23 |
| 11390610 |
Piperazine derivatives as MAGL inhibitors |
Joerg Benz, Benoit Hornsperger, Bernd Kuhn, Hans Richter, Buelent Kocer +6 more |
2022-07-19 |
| 11339120 |
Phenyl derivatives as cannabinoid receptor 2 agonists |
Olivier Gavelle, Matthias Nettekoven, Stephan Roever, Mark Rogers-Evans, Didier Rombach |
2022-05-24 |
| 11117903 |
Pyridine derivatives |
Beat Frei, Luca Gobbi, Fabienne Ricklin, Stephan Roever, Mark Rogers-Evans +1 more |
2021-09-14 |
| 10457686 |
[1,2,3]triazolo[4,5-D]pyrimidine derivatives |
Luca Gobbi, Wolfgang Guba, Julian Kretz, Rainer E. Martin, Matthias Valentin Westphal |
2019-10-29 |
| 10457684 |
[1,2,3]triazolo[4,5-d]pyrimidine derivatives |
Luca Gobbi, Wolfgang Guba, Julian Kretz, Rainer E. Martin, Matthias Valentin Westphal |
2019-10-29 |
| 10457685 |
[1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor |
Luca Gobbi, Wolfgang Guba, Julian Kretz, Rainer E. Martin, Matthias Valentin Westphal +1 more |
2019-10-29 |
| 10450321 |
[1,2,3]triazolo[4,5-D]pyrimidine derivatives |
Luca Gobbi, Wolfgang Guba, Julian Kretz, Rainer E. Martin, Matthias Valentin Westphal +1 more |
2019-10-22 |
| 10308659 |
Pyridine derivatives |
Olivier Gavelle, Atsushi Kimbara, Matthias Nettekoven, Roever Stephan, Mark Rogers-Evans +2 more |
2019-06-04 |
| 10227308 |
Radiolabeled cannabinoid receptor 2 ligand |
Simon M. Ametamey, Juergen Fingerle, Luca Gobbi, Ahmed Haider, Thomas Hartung +4 more |
2019-03-12 |
| 10183946 |
Triazolo[4,5-D]pyrimidines |
Matthias Nettekoven, Mark Rogers-Evans, Sebastien Schmitt, Benjamin James Stenton |
2019-01-22 |
| 9694012 |
Pyrazol derivatives |
Atsushi Kimbara, Matthias Nettekoven, Fabienne Ricklin, Stephan Roever, Mark Rogers-Evans +1 more |
2017-07-04 |
| 9593123 |
Triazolo[4,5-D]pyrimidine derivatives |
Matthias Nettekoven, Mark Rogers-Evans, Stephan Roever, Sebastien Schmitt, Atsushi Kimbara |
2017-03-14 |
| 9580435 |
Pyrrolo[2,3-D]pyrimidine derivatives as CB2 receptor agonists |
Atsushi Kimbara, Matthias Nettekoven, Stephan Roever, Mark Rogers-Evans, Tanja Schulz-Gasch |
2017-02-28 |
| 9522886 |
Pyridine derivatives |
Beat Frei, Luca Gobbi, Atsushi Kimbara, Matthias Nettekoven, Stephan Roever +2 more |
2016-12-20 |
| 9512141 |
Pyrazine derivatives as CB2 receptor agonists |
Baledi Dhurwasulu, Matthias Nettekoven, Stephan Roever, Mark Rogers-Evans, Tanja Schulz-Gasch |
2016-12-06 |
